Form 4 for CRMD CorMedix Inc.
Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-10 · accession 0001213900-22-025973 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-12 | 2022-05-10 | CRMD | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +207.5K | 207.5K | New | $0 |
| D | 2022-05-12 | 2022-05-10 | CRMD | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +500.0K | 500.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-10 | A | A | 207,469 | $0.00 | 207,469 | D | — | — | (F1) These Restricted Stock Units were granted on 5/10/2022. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest as follows: 50% on the first anniversary of the grant date, 30% on the second anniversary of the grant date, and the remaining 20% on the third anniversary of the grant date, subject to continued service through the applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy Common Stock) | 2022-05-10 | A | A | 500,000 | $0.00 | 500,000 | D | $3.38 · — to 2032-05-09 | 500,000 Common Stock | (F2) These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. |